MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-19-2026
Pulse Biosciences Operating Cash Flow 2011-2026 | PLSE
Annual Operating Cash Flow Pulse Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -54.1 M | -36.3 M | -33 M | -47 M | -54.1 M | -35.4 M | -34.2 M | -23.9 M | -11.1 M | -8.05 M | -3.32 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -3.32 M | -54.1 M | -31 M |
Quarterly Operating Cash Flow Pulse Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -13.5 M | - | - | - | -9.78 M | - | - | - | -6.57 M | - | -39 M | -28.4 M | -15.6 M | - | -41.4 M | -28.1 M | -11.7 M | - | -26.1 M | -17.6 M | -9.62 M | - | -25 M | -17 M | -7.33 M | - | -17.6 M | -10.7 M | -5.02 M | - | -7.12 M | -3.71 M | -2.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -2.5 M | -41.4 M | -16.4 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M |  USA |
 |
iRhythm Technologies
IRTC
|
80.9 M | $ 127.76 | 4.42 % | $ 4.09 B | USA |
 |
Repro Med Systems
KRMD
|
462 K | $ 4.07 | 2.65 % | $ 188 M | USA |
 |
Microbot Medical
MBOT
|
-13 M | $ 2.17 | -1.14 % | $ 99.4 M |  Israel |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.32 | 0.37 % | $ 26.3 M | USA |
 |
Alcon
ALC
|
1.34 B | $ 76.16 | 0.47 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
-11.8 M | $ 11.1 | -0.72 % | $ 26.9 M | USA |
 |
STERIS plc
STE
|
1.15 B | $ 222.32 | 0.23 % | $ 21.9 B | USA |
 |
The Cooper Companies
COO
|
796 M | $ 65.0 | 0.9 % | $ 12.9 B | USA |
 |
Utah Medical Products
UTMD
|
14.7 M | $ 67.76 | 0.87 % | $ 220 M | USA |
 |
Haemonetics Corporation
HAE
|
182 M | $ 61.27 | 2.24 % | $ 3.08 B | USA |
 |
electroCore
ECOR
|
-8.19 M | $ 6.17 | -0.08 % | $ 52.3 K | USA |
 |
ICU Medical
ICUI
|
180 M | $ 123.83 | -0.79 % | $ 3.05 B | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 26.83 | 0.13 % | $ 4.51 B | USA |
 |
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
3.03 B | $ 476.76 | -1.13 % | $ 170 B | USA |
 |
West Pharmaceutical Services
WST
|
755 M | $ 302.65 | -1.06 % | $ 21.9 B | USA |
 |
Glaukos Corporation
GKOS
|
-57.8 M | $ 122.71 | 1.01 % | $ 5.94 B | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 178.63 | - | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
17.5 M | $ 10.83 | 4.74 % | $ 224 M | USA |
 |
Merit Medical Systems
MMSI
|
297 M | $ 67.65 | -1.36 % | $ 4 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
235 M | $ 11.9 | -0.13 % | $ 2.37 B | USA |
 |
Retractable Technologies
RVP
|
-7.06 M | $ 0.64 | -2.05 % | $ 19.2 M | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 51.46 | -1.23 % | $ 169 M | USA |
 |
LeMaitre Vascular
LMAT
|
81.3 M | $ 115.76 | 2.04 % | $ 2.62 B | USA |
 |
Predictive Oncology
POAI
|
-12.4 M | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
-34.2 M | $ 26.3 | 2.45 % | $ 1.3 B | USA |
 |
BioLife Solutions
BLFS
|
8.43 M | $ 21.55 | 0.78 % | $ 993 M | USA |
 |
Stereotaxis
STXS
|
-13.7 M | $ 1.94 | 0.52 % | $ 176 M | USA |
 |
Baxter International
BAX
|
845 M | $ 18.33 | 0.91 % | $ 9.4 B | USA |
 |
ResMed
RMD
|
351 M | $ 221.76 | 0.87 % | $ 32.4 B | USA |
 |
AtriCure
ATRC
|
57.3 M | $ 29.41 | 0.43 % | $ 1.4 B | USA |
 |
Harvard Bioscience
HBIO
|
6.73 M | $ 6.69 | -2.48 % | $ 297 M | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 11.14 | 0.36 % | $ 455 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 151.85 | -0.18 % | $ 43.7 B | USA |
 |
Nephros
NEPH
|
827 K | $ 3.01 | 4.88 % | $ 31.3 M | USA |
 |
OraSure Technologies
OSUR
|
-49 M | $ 2.99 | -0.5 % | $ 220 M | USA |
 |
Repligen Corporation
RGEN
|
114 M | $ 118.32 | 0.61 % | $ 6.59 M | USA |